Glenview Trust’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $460K | Buy |
3,800
+84
| +2% | +$10.2K | 0.01% | 384 |
|
|
2025
Q1 | $414K | Buy |
3,716
+1
| +0% | +$111 | 0.01% | 377 |
|
|
2024
Q4 | $362K | Buy |
3,715
+8
| +0.2% | +$778 | 0.01% | 393 |
|
|
2024
Q3 | $426K | Buy |
3,707
+12
| +0.3% | +$1.38K | 0.01% | 376 |
|
|
2024
Q2 | $393K | Buy |
3,695
+238
| +7% | +$25.3K | 0.01% | 381 |
|
|
2024
Q1 | $334K | Buy |
3,457
+78
| +2% | +$7.55K | 0.01% | 386 |
|
|
2023
Q4 | $341K | Buy |
3,379
+102
| +3% | +$10.3K | 0.01% | 386 |
|
|
2023
Q3 | $334K | Sell |
3,277
-120
| -4% | -$12.2K | 0.01% | 365 |
|
|
2023
Q2 | $343K | Hold |
3,397
| – | – | 0.01% | 369 |
|
|
2023
Q1 | $313K | Hold |
3,397
| – | – | 0.01% | 371 |
|
|
2022
Q4 | $308K | Hold |
3,397
| – | – | 0.01% | 362 |
|
|
2022
Q3 | $258K | Hold |
3,397
| – | – | 0.01% | 365 |
|
|
2022
Q2 | $287K | Sell |
3,397
-124
| -4% | -$10.5K | 0.01% | 354 |
|
|
2022
Q1 | $309K | Hold |
3,521
| – | – | 0.01% | 361 |
|
|
2021
Q4 | $308K | Buy |
+3,521
| New | +$308K | 0.01% | 360 |
|
|
2020
Q2 | – | Sell |
-2,672
| Closed | -$220K | – | 334 |
|
|
2020
Q1 | $220K | Sell |
2,672
-237
| -8% | -$19.5K | 0.02% | 293 |
|
|
2019
Q4 | $275K | Sell |
2,909
-181
| -6% | -$17.1K | 0.02% | 299 |
|
|
2019
Q3 | $269K | Buy |
+3,090
| New | +$269K | 0.02% | 302 |
|
|
2017
Q1 | – | Sell |
-3,942
| Closed | -$257K | – | 323 |
|
|
2016
Q4 | $257K | Buy |
+3,942
| New | +$257K | 0.02% | 276 |
|